Rubicon Organics Announces the Results of the Annual General and Special Meeting, Appoints Chair & Grants DSUs
Rubicon Organics (OTCQX: ROMJF), a premium cannabis producer, held its Annual General and Special Meeting with 46.3% shareholder representation. Shareholders approved all proposed matters, including setting the board size at eight directors and electing all nominated directors with approval rates ranging from 85.7% to 95.8%.
The company announced a significant leadership change as Len Boggio steps down as Board Chair, transitioning to Chair of the Nomination and Governance Committee. Doris Bitz, an independent director since 2023 with over 30 years of CPG and manufacturing experience, has been appointed as the new Board Chair.
Shareholders also approved amendments to the company's Omnibus Equity Incentive Plan with 74.7% support. The plan allows for a maximum of 8,960,180 Common Shares for equity awards. Additionally, the company granted 1,024,576 DSUs to independent directors, vesting in twelve months.
Rubicon Organics (OTCQX: ROMJF), produttore di cannabis di alta qualit脿, ha tenuto la sua Assemblea Generale Annuale e Straordinaria con una rappresentanza azionaria del 46,3%. Gli azionisti hanno approvato tutte le questioni proposte, inclusa la determinazione del numero di membri del consiglio a otto direttori e l'elezione di tutti i candidati con tassi di approvazione compresi tra il 85,7% e il 95,8%.
L'azienda ha annunciato un importante cambiamento nella leadership: Len Boggio si dimette da Presidente del Consiglio, assumendo il ruolo di Presidente del Comitato Nomine e Governance. Doris Bitz, direttore indipendente dal 2023 con oltre 30 anni di esperienza nel settore dei beni di consumo e manifatturiero, 猫 stata nominata nuovo Presidente del Consiglio.
Gli azionisti hanno inoltre approvato le modifiche al Piano Omnibus di Incentivi Azionari con un 74,7% di supporto. Il piano prevede un massimo di 8.960.180 azioni ordinarie destinate a premi azionari. Inoltre, la societ脿 ha assegnato 1.024.576 DSU ai direttori indipendenti, con maturazione prevista in dodici mesi.
Rubicon Organics (OTCQX: ROMJF), un productor premium de cannabis, celebr贸 su Junta General Anual y Extraordinaria con una representaci贸n accionarial del 46.3%. Los accionistas aprobaron todos los asuntos propuestos, incluyendo fijar el tama帽o del consejo en ocho directores y elegir a todos los directores nominados con tasas de aprobaci贸n que oscilaron entre el 85.7% y el 95.8%.
La empresa anunci贸 un cambio significativo en el liderazgo ya que Len Boggio renuncia como Presidente del Consejo, pasando a ser Presidente del Comit茅 de Nominaciones y Gobernanza. Doris Bitz, directora independiente desde 2023 con m谩s de 30 a帽os de experiencia en bienes de consumo y manufactura, ha sido nombrada nueva Presidenta del Consejo.
Los accionistas tambi茅n aprobaron enmiendas al Plan Omnibus de Incentivos de Capital de la compa帽铆a con un 74.7% de apoyo. El plan permite un m谩ximo de 8,960,180 acciones comunes para premios de capital. Adem谩s, la empresa otorg贸 1,024,576 DSU a directores independientes, que se consolidan en doce meses.
Rubicon Organics (OTCQX: ROMJF)電� 頂勲Μ氙胳梽 雽�毵堨磮 靸濎偘鞐呾泊搿滌劀 46.3%鞚� 欤检＜ 於滌劃毳�搿� 鞐半 氚� 韸闺硠 欤检＜齑濏殞毳� 臧滌禍頄堨姷雼堧嫟. 欤检＜霌れ潃 鞚挫偓 靾橂ゼ 8氇呾溂搿� 靹れ爼頃橁碃, 氇摖 頉勲炒 鞚挫偓霌れ潉 85.7%鞐愳劀 95.8% 靷澊鞚� 彀劚毳犽 靹犾稖頃橂姅 霌� 鞝滌晥霅� 氇摖 鞎堦贝鞚� 鞀轨澑頄堨姷雼堧嫟.
須岇偓電� 欷戩殧頃� 毽崝鞁� 氤�頇旊ゼ 氚滍憸頄堨溂氅�, Len Boggio臧� 鞚挫偓須� 鞚橃灔歆侅棎靹� 氍茧煬雮� 於旍矞 氚� 瓯半矂雱岇姢 鞙勳洂須� 鞚橃灔鞙茧 鞝勴櫂頄堨姷雼堧嫟. 2023雲勲秬韯� 霃呺 鞚挫偓搿� 頇滊彊頃� 鞓� 靻岆箘鞛� 氚� 鞝滌“ 攵勳暭鞐愳劀 30雲� 鞚挫儊鞚� 瓴诫牓鞚� 臧�歆� Doris Bitz臧� 靸� 鞚挫偓須� 鞚橃灔鞙茧 鞛勲獏霅橃棃鞀惦媹雼�.
欤检＜霌れ潃 霕愴暅 須岇偓鞚� 齑濌磩 欤检嫕 鞚胳劶韹半笇 瓿勴殟 臧滌爼鞎堨潉 74.7%鞚� 彀劚鞙茧 鞀轨澑頄堨姷雼堧嫟. 鞚� 瓿勴殟鞚� 斓滊寑 8,960,180 氤错喌欤�毳� 欤检嫕 氤挫儊鞙茧 項堨毄頃╇媹雼�. 霕愴暅 須岇偓電� 霃呺 鞚挫偓霌れ棎瓴� 1,024,576 DSU毳� 攵�鞐枅鞙茧┌, 12臧滌洈 頉勳棎 鞕勳爠 旆摑霅╇媹雼�.
Rubicon Organics (OTCQX : ROMJF), producteur premium de cannabis, a tenu son Assembl茅e g茅n茅rale annuelle et extraordinaire avec une repr茅sentation des actionnaires de 46,3%. Les actionnaires ont approuv茅 toutes les r茅solutions propos茅es, y compris la fixation de la taille du conseil d'administration 脿 huit administrateurs et l'茅lection de tous les administrateurs nomin茅s avec des taux d'approbation allant de 85,7% 脿 95,8%.
L'entreprise a annonc茅 un changement important dans sa direction : Len Boggio d茅missionne de son poste de pr茅sident du conseil pour devenir pr茅sident du comit茅 de nomination et de gouvernance. Doris Bitz, administratrice ind茅pendante depuis 2023 avec plus de 30 ans d'exp茅rience dans les biens de consommation et la fabrication, a 茅t茅 nomm茅e nouvelle pr茅sidente du conseil.
Les actionnaires ont 茅galement approuv茅 des modifications au Plan d'incitation en actions omnibus de la soci茅t茅 avec un soutien de 74,7%. Ce plan permet un maximum de 8 960 180 actions ordinaires pour les attributions d'actions. De plus, la soci茅t茅 a attribu茅 1 024 576 DSU aux administrateurs ind茅pendants, avec une acquisition des droits sur douze mois.
Rubicon Organics (OTCQX: ROMJF), ein Premium-Cannabisproduzent, hielt seine j盲hrliche und au脽erordentliche Hauptversammlung mit einer Aktion盲rsvertretung von 46,3% ab. Die Aktion盲re genehmigten alle vorgeschlagenen Punkte, einschlie脽lich der Festlegung der Vorstandsgr枚脽e auf acht Direktoren und der Wahl aller nominierten Direktoren mit Zustimmungsraten zwischen 85,7% und 95,8%.
Das Unternehmen gab eine bedeutende F眉hrungs盲nderung bekannt, da Len Boggio als Vorstandsvorsitzender zur眉cktritt und zum Vorsitzenden des Nominierungs- und Governance-Ausschusses wechselt. Doris Bitz, seit 2023 unabh盲ngiges Vorstandsmitglied mit 眉ber 30 Jahren Erfahrung im Bereich Konsumg眉ter und Fertigung, wurde zur neuen Vorstandsvorsitzenden ernannt.
Die Aktion盲re stimmten auch 脛nderungen am Omnibus-Aktienanreizplan des Unternehmens mit 74,7% Zustimmung zu. Der Plan erlaubt maximal 8.960.180 Stammaktien f眉r Aktienpr盲mien. Zus盲tzlich gew盲hrte das Unternehmen 1.024.576 DSUs an unabh盲ngige Direktoren, die innerhalb von zw枚lf Monaten vesten.
- High shareholder approval rates for all proposals, with most directors receiving over 94% approval
- New Board Chair brings 30+ years of relevant CPG and manufacturing experience
- Strong corporate governance demonstrated through structured board transition and equity incentive plan updates
- Relatively low shareholder meeting participation at 46.3% of total shares
- Significant opposition to Incentive Plan amendment with 25.3% voting against
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (鈥淩ubicon Organics鈥� or the 鈥淐ompany鈥�), a licensed producer focused on cultivating and selling organic certified and premium cannabis, reports the voting results from its Annual General and Special Meeting of shareholders (the 鈥淢eeting鈥�) held earlier today.
A total of 31,130,021 shares were represented in person or by proxy at the Meeting, constituting approximately
Results of Annual General and Special Meeting
The following matters put forward before shareholders for consideration and approval as set out in Rubicon Organics鈥� management information circular dated June 27th, 2025 (the 鈥淐ircular鈥�) were approved by the shareholders:
- Setting the number of directors of the Company at eight;
- Electing Doris Bitz, Len Boggio, Margaret Brodie, Michael Detlefsen, Ian Gordon, Jesse McConnell,聽John Pigott, and Karen Proud as directors of the Company (together the 鈥淏oard鈥�) for the ensuing year until the next annual meeting of the Company;
- Appointing PricewaterhouseCoopers LLP as the Company鈥檚 auditors for the ensuing year with the Company鈥檚 directors authorized to fix their remuneration; and
- Approval of the amendment to the Company鈥檚 Omnibus Equity Incentive Plan
| Question | Yes | No | Abstain |
| Number of Directors at Eight (8) | 鈥� | ||
| Elect as Director, Doris Bitz | 鈥� | ||
| Elect as Director, Margaret Brodie | 鈥� | ||
| Elect as Director, Len Boggio | 鈥� | ||
| Elect as Director, Michael Detlefsen | 鈥� | ||
| Elect as Director, Ian Gordon | 鈥� | ||
| Elect as Director, Jesse McConnell | 鈥� | ||
| Elect as Director, John Pigott | 鈥� | ||
| Elect as Director, Karen Proud | 鈥� | ||
| Appointment of Auditor | 鈥� | ||
| Approval of Incentive Plan | 鈥� |
A corporate presentation presented at the Meeting is available for viewing on Rubicon Organics鈥� website at聽.
Change to Board Chair
The Company also today announced that Len Boggio will step down as Chair of the Board, effective immediately. He will transition to the role of Chair of the Nomination and Governance Committee.
The Board has unanimously appointed Doris Bitz, currently serving as independent director since 2023, as the incoming Chair. She brings over 30 years of experience successfully building, scaling and growing manufacturing and CPG businesses in North America. In 2022 she retired from her role as President, Retail of Dessert Holdings, a leading manufacturer of high-quality dessert products, and now serves on multiple boards. Doris has also held executive marketing positions at top-tier CPG companies including PepsiCo Canada and General Mills. Doris holds an HBA and an MBA from the Ivey School of Business at Western University.
鈥淥n behalf of the organization, I want to thank Len Boggio for his leadership as Board Chair over the last 2 years in particular his exemplary leadership and commitment to strong corporate governance, and I鈥檓 pleased that he will continue to share his extensive governance experience in his role as Chair of the Nomination and Governance Committee,鈥� said Margaret Brodie, Chief Executive Officer. 鈥淚 want to welcome Doris Bitz as our new Board Chair. Doris has unique experience in building and scaling businesses and thus is very well-positioned to help elevate our team as we transform and scale in our next phase of growth.鈥�
鈥淚'm honored to step into the role of Chair,鈥� said Doris Bitz. 鈥淚 look forward to working closely with the leadership team and Board to scale Rubicon Organics to achieve our vision to be the most trusted, premium global leader in cannabis, building long-term value for shareholders.鈥�
Omnibus Equity Incentive Plan
The Board of Directors (the 鈥淏oard鈥�) approved the amendment to the Omnibus Equity Incentive Plan on June 27th, 2025, subject to receipt of shareholder approval at the Meeting. The amended Omnibus Equity Incentive Plan will be administered by the Company鈥檚 Board, and will permit the grant or issue of Restricted Share Units (鈥淩SU鈥檚鈥�), Performance Share Units (鈥淧SU鈥檚鈥�), Deferred Share Units (鈥淒SU鈥檚鈥�), and options (鈥淥ptions鈥�) to eligible participants.
The amended Omnibus Equity Incentive Plan is a fixed plan which provides that the aggregate maximum number of Common Shares that may be issued upon the exercise or settlement of awards granted under the amended Omnibus Equity Incentive Plan is 8,960,180 Common Shares. As set out in the Circular, the Omnibus Equity Incentive Plan replaced the Company鈥檚 legacy equity incentive plan and legacy DSU plan, and as such, no further grants of stock awards or DSUs will be made under the legacy equity incentive plan or legacy DSU plan.
DSU Grant
The Company has granted an aggregate of 1,024,576 DSUs pursuant to the Omnibus Equity Incentive Plan to certain independent directors of the Company as compensation for their services in advance for the following 12 months. The DSUs will vest twelve months from the date of grant, and may only be redeemed upon a holder ceasing to be a director of the Company, or as allowed for under the terms of the Omnibus Equity Incentive Plan.
ABOUT RUBICON ORGANICS INC.
Rubicon Organics is the Canadian leader in certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the company is scaling a house of trusted, high-performing brands including Simply Bare鈩� Organics, 1964 Supply Co.鈩�, Wildflower鈩�, and Homestead Cannabis Supply鈩�.
The Company鈥檚 production base is anchored by its Delta, BC Facility, and is now complemented by the acquisition of our Hope, BC Facility, which will expand production capacity by over
As the Canadian market continues to rationalize and global demand for high-quality cannabis increases, Rubicon鈥檚 disciplined execution, brand equity, and consumer loyalty set it apart. The Company鈥檚 focus on premium quality, innovation, and operational execution has driven consistent revenue growth and positive Adjusted EBITDA.
Rubicon Organics represents a rare combination of category leadership, operational strength, and long-term growth potential.
CONTACT INFORMATION
Margaret Brodie
Chief Executive Officer
Phone: +1 (437) 929-1964
Email:
The TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics鈥� goal of achieving industry leading profitability are 鈥渇orward-looking statements鈥�. Forward-looking information can be identified by the use of words such as 鈥渨ill鈥� or variations of such word or statements that certain actions, events or results 鈥渨ill鈥� be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based on certain assumptions that management considers reasonable under the circumstances, the Company鈥檚 ability to execute its business strategy, demand for its products in international markets, and other factors beyond the Company鈥檚 control. These statements are based on current expectations, estimates, and projections about the Company鈥檚 business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company's ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
FAQ
What were the key voting results at Rubicon Organics (ROMJF) 2025 Annual Meeting?
Who is the new Board Chair of Rubicon Organics (ROMJF)?
What changes were made to Rubicon Organics' equity incentive plan in 2025?
How many DSUs did Rubicon Organics grant to directors in July 2025?
What was the shareholder participation rate at Rubicon Organics' 2025 Annual Meeting?
